| Financial Year |
March 31 2023 |
| Monetary Funds |
3,715,936,513.58 |
| Held-for-trading Financial Assets |
2,938,673,095.89 |
| Notes Receivable |
-- |
| Accounts Receivable |
809,653,351.48 |
| Advances to Suppliers |
75,399,843.44 |
| Other Receivables |
29,908,102.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,321,259,150.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
25,100,312.40 |
| Other Current Assets |
641,237,591.56 |
| Total Current Assets |
9,721,451,542.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
32,106,064.00 |
| Long-term Equity Investment |
242,607,630.34 |
| Investment Properties |
107,904,688.64 |
| Fixed Assetes |
2,069,667,940.17 |
| Under-construction Projects |
21,194,457.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
515,838,460.87 |
| R&D expenses |
-- |
| Goodwill |
1,109,753,277.27 |
| Long-Term Deferred and Prepaid Expenses |
44,215,964.53 |
| Deferred Income Tax Assets |
137,360,344.30 |
| Other Non-Current Assets |
98,013,280.01 |
| Sub-Total of Non-Current Assets |
5,694,616,915.79 |
| Total Assets |
15,416,068,458.54 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
250,000,000.00 |
| Accounts Payable |
1,426,351,091.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
124,220,554.83 |
| Taxes Payable |
218,538,159.65 |
| Interest Payable |
-- |
| Dividend Payable |
616,102.93 |
| Other payables |
205,975,544.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
217,544,705.48 |
| Other Current Liabilities |
156,346,704.57 |
| Sub-Total of Current Liabilities |
2,817,779,738.09 |
| Long-term Loans |
1,492,147,980.26 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
45,083,062.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,817,788,506.51 |
| Total Liabilities |
4,635,568,244.60 |
| Paid-In Capital(Or Share Stock) |
1,002,476,929.00 |
| Capital Surplus |
1,994,720,853.55 |
| Surplus Reserve |
505,340,480.93 |
| LESS:Treasury Stock |
251,736,419.55 |
| Undistributed Profits |
7,327,576,327.19 |
| Minority Stockholder's Interest |
199,959,411.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,580,540,802.74 |
| Owner's Equity（Stockholder's Equity） |
10,780,500,213.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,416,068,458.54 |
